It was also found that intrathecal delivery of FSLLRY-NH2 attenuated the increased expression of glutamate receptor subunits GluR1 and NR2B in the dorsal horn of the rats with bone cancer (Figure 2D). The gene discussed is GRIA1; the disease is bone neoplasm.